Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States
[ad_1] A co-authored study: Real-world nAMD patients in the US receive fewer anti-VEGF injections and experience worse visual outcomes compared with patients in randomized clinical trials… http://www.ophthalmologyretina.org/article/S2468-6530(17)30297-X/fulltext Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States Real-world …